CliffBio
small molecule

MEPROBAMATE AND ASPIRIN

ASPIRIN; MEPROBAMATE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameMEPROBAMATE AND ASPIRIN
Active ingredientASPIRIN; MEPROBAMATE
Strength325MG;200MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1986
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MEPROBAMATE AND ASPIRIN patent cliff — loss of exclusivity — | CliffBio